Comparison of influence of ziprasidone and paliperidone on PANSS scores,PRL and body weight of female patients with schizophrenia
10.3760/cma.j.issn.1008-6706.2017.20.028
- VernacularTitle:齐拉西酮与帕利哌酮对女性精神分裂症患者PANSS评分、催乳素及体质量的影响比较
- Author:
Yan HE
;
Minqiao ZHANG
;
Yali HAN
;
Daping JIANG
- Keywords:
Schizophrenia;
Ziprasidone;
Paliperidone;
Female
- From:
Chinese Journal of Primary Medicine and Pharmacy
2017;24(20):3145-3148
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the influence of ziprasidone and paliperidone on PANSS scores,PRL and body weight of female patients with schizophrenia.Methods 140 female patients with schizophrenia were chosen,and they were randomly divided into group A (70 patients) with ziprasidone and group B (70 patients) with paliperidone.The clinical efficacy,PANSS score,PRL levels and body weight before and after treatment,and incidence of adverse effects were compared between the two groups.Results There was no significant difference in the clinical effects between the two groups (x2 =1.27,P ＞ 0.05).After treatment,the PANSS scores of both two groups were significantly better than those before treatment (t =2.78,3.31,3.06,3.50,2.90,3.38,3.17,3.62,all P ＜ 0.05).There was no significant difference in PANSS score after treatment between the two groups (t =1.08,1.20,0.97,0.88,all P ＞ 0.05).After treatment,the PRL level of group A was significantly higher than that before treatment (t =2.65,P ＜ 0.05).There was no significant difference in PRL level of group B between before and after treatment(t =1.24,P ＞ 0.05).There were no significant differences in the body weight between the two groups (t =1.10,0.97,0.88,all P ＞ 0.05).There was no significant difference in the incidence of adverse reactions between the two groups (x2 =1.03,P ＞ 0.05).Conclusion Ziprasidone and paliperidone in the treatment of female patients with schizophrenia has the same clinical effects and safety;but compared with paliperidone,ziprasidone in the treatment of female patients with schizo-phrenia can efficiently avoid the impact on the PRL levels of patients and reduce the risk of high serum PRL.
